Council for Innovation Procurement in Health Care
The sustainability of Canada’s public health care system will depend in large part on innovations that can enhance the efficiency, safety, quality, and productivity of health and health care services. Every year, governments in Canada spend billions of public dollars on products and services. If used appropriately, this purchasing power could boost innovations in the health care sector and improve system performance. The experience in other countries suggests that Canada has a compelling opportunity to accelerate the development and adoption of innovation in public health care by transforming its procurement processes.
The Council for Innovation Procurement in Health Care focuses on three core objectives:
- Discuss how to enable a shift from cost control to value creation. Identify actions that will help you and other Canadian leaders use innovation procurement tools effectively to increase value for money.
- Share knowledge and good practices related to innovation procurement processes.
- Enhance the capacity of organizations to transform their procurement processes and improve performance.
The Council for Innovation Procurement in Health Care is a forum that will provide you with the opportunity to establish linkages with leading organizations around the world to further learnings and good practices in this area. It works to identify and review transformations in Canada and other countries with an aim to leverage procurement processes, assess gaps in Canada’s approach to innovation in procurement, shift the focus of procurement from cost control to value creation, and identify actions that will help you to effectively use innovative procurement tools to attain more value for money and enhance organizational performance.
Value-Based Procurement of Innovative Medicines
On June 6, 2017 the Value-Based Pricing and Procurement of Innovative Medicines Roundtable was convened in Toronto by The Conference Board of Canada. The roundtable was made possible through the support of the Health Research Foundation and Innovative Medicines Canada.
The roundtable provided an opportunity to discuss the merits of value-based pricing and procurement of innovative medicines, and the appropriateness and applicability of the case studies to Canadian jurisdictions. It informed constructive dialogue about the adoption of similar practices in Canada with a view toward improving health outcomes and health care sustainability.
We are pleased to share the executive roundtable highlights from that session.
Spring 2018 Conference
Value-Based Procurement and Innovation 2018 Conference
April 18, 2018 • Hotel TBD • Toronto, ON